
簡介
NMN and NMNH are both NAD+ precursor ingredients, but they are not equal from a supplement manufacturing perspective. NMN is the more established ingredient, with a longer research history, broader supplier availability, and more mature dosage-form experience. NMNH is a newer reduced form that may show stronger NAD+ elevation in early preclinical research, but it also brings more uncertainty around stability, long-term human data, raw material handling, and finished-product shelf life.
For supplement brands, the real question is not simply “Which one is stronger?” The better question is: which ingredient can be sourced consistently, tested reliably, manufactured into a stable product, supported with appropriate documentation, and positioned responsibly in your target market?
This guide compares NMN and NMNH from a formulation and manufacturing angle: evidence maturity, raw material purity, HPLC testing, stability risk, capsule/tablet/gummy feasibility, packaging, storage, and regulatory considerations. If you are building a next-generation NAD+ supplement, these practical details matter as much as the marketing story.
Quick Answer: NMN vs NMNH for Supplement Brands
Choose NMN when your priority is a better-established ingredient with broader human research, more predictable supply, and easier finished-product development. NMN is usually the more practical choice for capsules, tablets, powders, and private-label NAD+ supplement lines.
Consider NMNH only when your brand is prepared for a more experimental positioning, stronger stability controls, tighter supplier qualification, and more cautious claim language. NMNH may be scientifically interesting, but it should not be treated as a simple “better NMN” without reviewing stability data, purity testing, and regulatory status.
In short: NMN is the safer commercial starting point. NMNH is a next-generation option that requires stronger R&D, QA, packaging, and documentation support.
什麼是 NMN?
NMN is a naturally occurring molecule found in trace amounts in foods like broccoli, cabbage, and avocados. It serves as a direct precursor to NAD+, which powers cellular processes such as energy metabolism, DNA repair, and gene expression. Aging reduces NAD+ levels by up to 50% by middle age, leading to fatigue, reduced muscle function, and increased disease risk. NMN supplements aim to replenish NAD+ to support anti-aging and overall wellness.
If you are sourcing NMN for capsules or powders, review our beta-NMN raw material page for purity, storage, and documentation details.科學證據
有關 NMN 的研究十分紮實,尤其是在動物模型方面。2016 年的一項研究顯示,NMN 可改善小鼠的胰島素敏感性、心臟功能和能量代謝(Mills 等人,2016 年)。2020 年的一項人體試驗發現,每天 250 毫克的 NMN 可增強老年人的肌肉功能和有氧能力 (Irie 等人,2020)。其他研究顯示,NMN 可改善認知功能,預防神經退化性疾病,不過大規模的人體試驗仍在進行中。
NMN 的好處
- 能量代謝:增強線粒體功能,以產生更好的能量。
- DNA 修復:支持 PARPs 等酵素修復受損的 DNA。
- 心血管健康:改善血管功能,降低動脈僵硬度。
- 認知支援:可保護腦細胞,改善記憶力。
- 代謝健康:增強胰島素敏感性和葡萄糖代謝。
原材料
NMN 的製造過程如下:
- 生物發酵:酵母或細菌將 nicotinamide 和核糖轉換成 NMN,確保高純度 (通常為 98%+)。
- 化學合成:在受控的環境中結合化學前驅體,提供可擴充性,但需要嚴格的品質檢查。
高純度的 NMN 對於避免可能降低療效或造成副作用的污染物至關重要。
Manufacturing Notes for NMN
For brands developing NMN products, the most important manufacturing questions are purity, isomer control, moisture protection, and dosage-form compatibility. A high-quality NMN raw material should be supported by a Certificate of Analysis showing assay, identity, heavy metals, microbial limits, residual solvents if applicable, and HPLC purity.
NMN is commonly used in capsules, tablets, powders, and sublingual formats. Compared with NMNH, it is generally easier to source and easier to formulate, but it is still not a “set and forget” ingredient. The finished product should be protected from heat, light, and humidity, and the packaging system should be selected based on the intended shelf life and market.
For capsule products, brands should review bulk density, flowability, and capsule fill weight before committing to production. For tablets, compression behavior and excipient compatibility matter. For powders and stick packs, taste, hygroscopicity, and moisture barrier packaging become more important.
產品表格
NMN 有多種形式,可滿足不同的喜好:
- 膠囊/片劑:最受歡迎,提供精確劑量(每粒 100-500 毫克)。
- 粉末:可溶解於水或冰沙中,是快速吸收的理想選擇。
- 軟糖:可口的 NMN 軟糖吸引那些不喜歡吞嚥藥片的人。
- 液體:滴劑或口服溶液可快速吸收,但需要小心儲存以防止降解。
劑量與安全性
建議劑量為每日 250-500 毫克,通常在早上服用以配合晝夜節律。副作用非常罕見,但可能包括輕微噁心或頭痛。初步的人體研究證實其長期安全性,但建議您諮詢醫生,尤其是患有疾病的人。

什麼是 NMNH?
NMNH,或減少 煙醯胺單核苷酸, NMN 是一種較新的 NMN 衍生物,多了一個氫原子,使其成為還原型,可能更具活性。這種結構上的差異可能會增強其提升 NAD+ 水準的能力,並提供更強的抗氧化效果。NMNH 的研究較少,但有希望成為新一代的抗老化補充劑。.
科學證據
NMNH 研究尚處於起步階段。2023 年的一項小鼠研究發現,NMNH 增加 NAD+ 含量的速度比 NMN 快 2-3 倍,並顯示出優異的抗氧化特性(Zhang 等人,2023 年)。另一項研究指出,NMNH 可改善氧化壓力模型中的細胞修復功能 (Li 等人,2024)。人體試驗有限,因此有關 NMNH 效用的聲稱主要依賴臨床前的資料。
NMNH 的優點
- 增強 NAD+ 效能:可能更快、更有效率地產生 NAD+。
- 更強的抗氧化效果:比 NMN 更有效中和自由基。
- 改善生物利用率:初步數據顯示細胞吸收較佳。
- 細胞修復:可加強從氧化損傷中恢復。
原材料
NMNH 的生產更加複雜:
- 化學還原:NMN 經化學還原加入一個氫原子,需要先進的技術以維持穩定性。
- 高純度 NMN 基:從高品質的 NMN 開始,增加生產成本。
- 由於 NMNH 不如 NMN 穩定,因此需要嚴格的環境控制來防止降解。
Why NMNH Stability Is the Real Formulation Challenge

NMNH is often described as a more powerful or faster-acting NAD+ precursor, but for manufacturers the main challenge is stability. A compound can look promising in early research and still be difficult to turn into a reliable commercial supplement if it is sensitive to oxidation, moisture, heat, or processing stress.
This is why NMNH product development should start with a stability-first mindset. Brands should request raw material stability data, accelerated stability studies, recommended storage conditions, and packaging guidance before launching a finished product. Without this data, a product may test well at release but lose potency before the end of shelf life.
NMNH is also a weaker fit for gummies and liquid products unless the supplier and manufacturer can prove stability under realistic processing conditions. Gummies involve heat, water activity, sugar systems, acids, and long storage periods. Liquids introduce even more risk because dissolved actives can degrade faster than dry powders. For this reason, capsule or protected powder formats are usually more reasonable starting points for NMNH development.
產品表格
NMNH 的供應較少,但在以下地點提供:
- 膠囊/片劑:最常見,劑量為 100-300 毫克。
- 粉末:可溶解於水,靈活的定制劑量。
- 軟糖:由於高成本和穩定性問題,很少見。
- 液體:實驗性,在長期維持效力方面面臨挑戰。
劑量與安全性
建議的 NMNH 劑量為每日 100-300 毫克,但由於研究有限,最佳劑量尚不清楚。副作用並沒有詳盡的記錄,長期的安全性也尚未研究。使用者應謹慎使用,並諮詢醫療照護專業人員。
NMN vs NMNH:詳細比較
澄清 NMN 和 NMNH 差異, 下表對主要方面進行了比較:
| 外觀 | NMN | NMNH |
|---|---|---|
| 化學結構 | NAD+ 前體,穩定分子 | 具有額外氫的還原 NMN,可能更具反應性 |
| 提升 NAD+ | 有效,在研究中提高 NAD+ 20-40% | NAD+ 增加速度可能快 2-3 倍,人類數據有限 |
| 生物利用率 | 良好,尤其是粉末/液體形式 | 可能更高,但缺乏人體研究 |
| 抗氧化能力 | 溫和,支援細胞健康 | 更強,有效中和自由基 |
| 原材料 | 發酵或合成,符合成本效益 | 需要 NMN 還原,成本高且複雜 |
| 產品表格 | 膠囊、粉末、 NMN 軟糖液體 | 膠囊、粉末、稀有 軟糖/液體 |
| 研究成熟度 | 廣泛的動物和人類研究 | 早期階段,大多為動物研究 |
| 價格 (30 天供應量) | $30-60,廣泛可用 | $50-100,供應有限 |
| 穩定性 | 穩定、易於存放 | 較不穩定,需要小心處理 |
Formulation and manufacturing feasibility table
| Formulation factor | NMN | NMNH | B2B note |
| Research maturity | More established, including human trials | Early-stage, mostly preclinical evidence | NMN is easier to support with responsible marketing language. |
| Raw material availability | Broader supplier base | Limited supplier base | NMNH requires stricter supplier qualification. |
| 穩定性 | More manageable, but still moisture/heat sensitive | Higher stability concern | NMNH needs stronger packaging and stability data. |
| 膠囊 | Practical | Possible with controls | Capsules are the safest first format for both. |
| 錠劑 | Possible with excipient testing | Higher compression/stability risk | Pilot tableting is essential. |
| 軟糖 | Possible but not ideal for high potency | Generally high risk | Avoid NMNH gummies unless stability is proven. |
| 液體 | Possible but needs stability work | Experimental/high risk | Dry formats are safer. |
| Quality testing | HPLC, assay, impurities, heavy metals, microbes | Same plus stronger stability monitoring | COA alone is not enough; review method and stability. |

深入分析
- 化學結構:NMNH 的額外氫能增強其還原能力,可能使其更有效地增強 NAD+。然而,它的不穩定性需要精確的製造過程。
- NAD+ 提升效率:NMNH 可能會更快地增加 NAD+,但 NMN 的效果在人類身上有更好的記錄。
- 生物利用率:NMNH 的結構顯示其更易被細胞吸收,但 NMN 的吸收則透過各種形式 (如 NMN 軟糖和液體) 達到最佳化。
- 抗氧化效果:NMNH 的還原形式可提供優異的保護,防止造成老化和疾病的氧化壓力。
- 原料與生產:NMN 的生產過程較簡單,因此更容易獲得。NMNH 複雜的製程限制了可擴充性並提高了成本。
- 產品表格:NMN 的多樣性,包括 NMN 軟糖,迎合不同的喜好。NMNH 的有限形式反映了其較新的市場佔有率。
- 研究與成本:NMN 的廣泛研究使其成為較安全的賭注,而 NMNH 較高的價格反映了其新穎性和生產上的挑戰。
Which Ingredient Should Brands Choose?
Choose NMN if your brand needs a more mature NAD+ precursor ingredient with broader market awareness, more available suppliers, and better finished-product experience. NMN is generally more suitable for mainstream longevity supplements, private-label capsule products, sublingual powders, and first-time NAD+ product launches.
Choose NMNH only if your brand is prepared for a more technical development process. NMNH may offer an interesting next-generation story, but it requires stronger R&D review, stricter raw material qualification, stability-first formulation, and cautious claims. It is better suited for brands with a science-led positioning and the budget to support testing and documentation.
If your goal is speed to market, NMN is usually the more practical choice. If your goal is differentiation and you are willing to manage stability and evidence limitations, NMNH can be explored as an advanced ingredient.
Packaging and Storage Recommendations
Packaging should be selected based on the ingredient’s stability profile, not only on cost or appearance. NMN products may be suitable for HDPE bottles, blister packs, stick packs, or foil sachets depending on dosage form and shelf-life target. NMNH products generally require a more conservative approach.
For NMNH, brands should consider:
– high-barrier bottles,
– desiccants,
– aluminum foil sachets,
– blister packaging,
– double-aluminum blister packs for premium formulas,
– reduced headspace,
– oxygen and moisture barrier review,
– and accelerated stability testing before launch.
The best packaging decision is not always the cheapest one. If an ingredient is unstable, weak packaging can destroy the commercial value of the formula before the consumer ever opens the bottle.
Quality Checklist Before Sourcing NMN or NMNH
Before purchasing NMN or NMNH raw material, supplement brands should request a full technical document package. At minimum, the review should include:
– Certificate of Analysis (COA)
– HPLC assay and identity method
– Chromatogram or method summary, if available
– Purity specification
– Impurity profile
– Heavy metals
- 微生物限度
- 殘留溶劑(如適用
– Water content or loss on drying
– Particle size and bulk density
– Stability data
– Recommended storage conditions
- 過敏原聲明
– GMO statement
- 原產地
– Manufacturing process summary
– Packaging recommendation
– Regulatory support documents
For NMNH, stability data should be treated as essential, not optional. A 98%+ purity claim is not enough if the ingredient degrades rapidly under normal storage, blending, compression, or packaging conditions.
預防措施
- 醫療諮詢:由於安全數據有限,對 NMNH 來說是必要的。NMN 的安全性較為確立,但仍需專業建議。
- 品質保證:選擇通過第三方測試(如 NSF 或 USP 認證)且純度達 98%+ 的產品,以確保功效和安全性。
- 副作用:NMN 在極少數情況下可能會引起輕微噁心或疲勞。NMNH 的副作用尚不清楚,請密切注意不良反應。
- 儲存:NMNH 不穩定,需要陰涼乾燥的儲存環境。NMN 較為寬鬆,但仍需要適當的處理。
How to Read an NMN/NMNH COA and HPLC Result

A COA should do more than state “98% purity.” For NAD+ precursor ingredients, brands should pay attention to the test method, identity confirmation, chromatogram clarity, and impurity peaks.
When reviewing a supplier document, ask:
1. Does the COA identify the exact ingredient form?
For NMN, beta-NMN identity matters. For NMNH, confirm that the supplier is not simply marketing standard NMN under a reduced-form name.
2. Is the assay method clearly stated?
HPLC is commonly used for assay and purity testing, but brands should review whether the method is validated and whether the supplier can provide supporting data.
3. Are impurities visible and controlled?
A clean headline purity number may hide meaningful impurity peaks. Ask for chromatogram support when sourcing high-value ingredients.
4. Is the batch tested for storage-sensitive degradation?
This is especially important for NMNH. A fresh batch may pass release testing but still fail shelf-life expectations if stability is weak.
For B2B buyers, documentation quality often reveals supplier quality. If a supplier cannot provide clear analytical support, the ingredient should be treated as higher risk.

總結
NMN 補充劑和 NMNH 補充劑都能為抗衰老和優化健康帶來令人信服的好處。NMN 以其經濟實惠、廣泛的研究和多樣化的形式成為人們的首選,例如 NMN 軟糖 和液體。NMNH 雖然有潛在的 NAD+ 增強效率和抗氧化效果,但價格較高且研究較少,吸引那些願意探索尖端選擇的人。您的選擇取決於預算、健康目標以及對產品形式的偏好。請務必優先選擇高品質的產品,並諮詢醫療保健提供者,以確保安全性和適用性。
Ready to evaluate NMN, NMNH, or another NAD+ precursor? Contact our formulation team with your target market, dosage form, and stability requirements.常見問題
NMNH 是否比 NMN 更好?
Not necessarily. NMNH may show stronger NAD+ elevation in early preclinical research, but NMN has more mature human data, broader commercial use, and easier formulation experience. For most brands, NMN is the more practical starting point, while NMNH is a higher-risk next-generation option that requires stronger stability and documentation support.
What is the main difference between NMN and NMNH?
NMN is an oxidized NAD+ precursor, while NMNH is a reduced form with different redox behavior. The difference is not only biochemical. It also affects raw material handling, stability, packaging, and finished-product feasibility.
Can NMNH be used in gummies?
NMNH gummies are generally high risk unless the supplier and manufacturer can provide convincing stability data. Gummies involve heat, water activity, sweeteners, acids, and long storage periods, all of which can increase degradation risk for sensitive ingredients.
What product form is best for NMN?
Capsules and tablets are usually the most practical NMN formats. Powders and stick packs can also work if moisture protection and taste are controlled. Liquid formats require more stability work.
What product form is best for NMNH?
For NMNH, capsules or protected dry powder formats are usually the safest first options. Liquids and gummies should be treated as experimental until stability is proven.
What should brands check before buying NMN or NMNH raw material?
Brands should request COA, HPLC assay, identity testing, impurity profile, heavy metals, microbial limits, residual solvents if applicable, water content, stability data, storage guidance, and regulatory support documents.
Is NMN or NMNH legal in every market?
No. Regulatory status can vary by country and can change over time. Brands should review the current rules in their target markets and consult regulatory professionals before launching NAD+ precursor products.
Can Gensei help develop NMN or NMNH finished products?
Yes. A manufacturing partner can help review raw material quality, dosage form feasibility, excipient compatibility, packaging, stability testing, and private-label production requirements for NAD+ supplement products.
引用
- Mills et al. 2016 – Long-term administration of NMN mitigates age-associated physiological decline in mice
- Irie et al. 2020 – Effect of oral NMN administration on clinical parameters in healthy men
- Yoshino et al. 2021 – NMN increases muscle insulin sensitivity in prediabetic women
- Liu et al. 2021 – Reduced nicotinamide mononucleotide potently enhances NAD+
- Zapata-Pérez et al. 2021 – Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor
- NIH PMC review – NAD+ precursors NMN and NR review
- FDA Q&A on dietary supplements, NDI, claims, and manufacturer responsibility
- FDA Structure/Function Claims
- Regulations.gov FDA docket PDF on NMN petition/ingredient status (if accessible)
- Venable analysis on FDA 2025 NMN position reversal
- USP Dietary Supplement Verification Program

W. Wenyang 是一位資深專家,在膳食補充劑供應鏈領域擁有豐富經驗,尤其在膠原蛋白肽、骨湯蛋白及角蛋白等核心成分的研發、製程控制與全球採購方面具備深厚的實務經驗。 身為本專欄的作者,他致力於剝去行銷包裝的表象,將晦澀的成分科學與生產品質控制標準,轉化為淺顯易懂的硬核科普,協助讀者看清標籤背後的真相,並做出更理性的健康選擇。.
